文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

意大利猪源耐碳青霉烯大肠埃希菌中携带blaNDM-4的新型IncFII质粒

Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该研究对2019年意大利一头育肥猪盲肠内容物中分离的blaNDM-4阳性大肠埃希菌进行纳米孔长读长与Illumina短读长联合分析。作者称这是欧洲首次在食用动物中检出产NDM肠杆菌目细菌。

要点

  • 欧洲首次在食用动物中报告产NDM肠杆菌目细菌,提示 livestock 储库风险
  • blaNDM-4位于新型IncFII质粒pMOL412_FII的16 kb多重耐药区,含1类整合子
  • pMOL412_FII与缅甸人源菌株的约90.3 kb pM109_FII质粒高度相关,提示跨境传播可能

核心结论

  • 研究首次在欧洲从食用动物(意大利育肥猪)中分离到blaNDM-4阳性多重耐药大肠埃希菌,并完成其携带质粒的全序列解析。
  • 作者建议采用One Health策略,比较不同来源和地区基因组数据,以追溯并控制质粒介导的碳青霉烯酶基因在动物、人类及食物链间的传播。

研究设计与样本

  • 研究类型为对单株细菌分离株的分子流行病学与基因组特征分析。
  • 样本为2019年从意大利一头育肥猪盲肠内容物中分离的1株blaNDM-4阳性大肠埃希菌。
  • 方法为Oxford Nanopore长读长与Illumina短读长联合生物信息学分析,用于in silico分型、blaNDM-4遗传背景确定及携带质粒完整重建。

主要发现

  • 分离株属于ST641和血清型O108:H23,携带多种毒力基因和质粒复制子。
  • 多重耐药表型为对全部β-内酰胺类、碳青霉烯类、磺胺甲噁唑和甲氧苄啶耐药,分别由blaTEM-1B、blaNDM-4、sul1/sul3和dfrA12介导。
  • pMOL412_FII与缅甸人源大肠埃希菌中携带blaNDM-4的约90.3 kb质粒pM109_FII高度相关。

关键数值与推荐

  • 分离株对全部β-内酰胺类、碳青霉烯类、磺胺甲噁唑和甲氧苄啶耐药。
  • pMOL412_FII与pM109_FII(约90.3 kb,缅甸人源分离株)高度相关。

临床怎么用

  • 对食用动物源肠杆菌目细菌应关注碳青霉烯酶基因监测,尤其NDM型。
  • 质粒完整序列分析有助于识别耐药基因水平转移载体及跨物种传播线索。
  • 提示临床与兽医领域需共享基因组数据,落实One Health监测。

局限性

  • 原文未报告该菌株的临床感染信息,仅来自猪盲肠内容物。
  • 原文未报告该质粒的接合转移实验或体外稳定性数据。
  • 原文为单株分离株描述,未提供区域流行率或样本量数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To the best of our knowledge, we describe the first evidence in Europe of an MDR, blaNDM-4-positive Escherichia coli isolated from a food-producing animal, harboured by a novel IncFII plasmid of which we report the complete sequence. METHODS: One blaNDM-4-positive E. coli isolated in 2019 from the caecal contents of a fattening pig in Italy was in-depth characterized by combined bioinformatic analysis of Oxford Nanopore long reads and Illumina short reads, for in silico typing, determination of the blaNDM-4 genetic context and full reconstruction of the blaNDM-4-carrying plasmid. RESULTS: The isolate belonged to ST641 and to the genoserotype O108:H23 and tested positive for different virulence genes and plasmid replicons. The MDR phenotype of resistance to all β-lactams, carbapenems, sulfamethoxazole and trimethoprim was mediated by blaTEM-1B, blaNDM-4, sul1/sul3 and dfrA12, respectively. The blaNDM-4 gene was harboured by a novel 53 043 bp IncFII plasmid (pMOL412_FII) composed of four main genetic regions, including an MDR region (MRR-NDM-4) of 16 kb carrying blaNDM-4 and several antimicrobial resistance genes located in a class 1 integron. pMOL412_FII was closely related to another ∼90.3 kb plasmid (pM109_FII) harbouring blaNDM-4 in an E. coli isolated from a human patient in Myanmar. CONCLUSIONS: To the best of our knowledge, we have identified for the first time in Europe an NDM-producing Enterobacterales in livestock and resolved the complete sequence of the novel pMOL412_FII plasmid harbouring blaNDM-4 in an MRR. A global One Health approach, comparing genomic data from different sources and geographical areas, may help to trace back and control possible plasmid-borne carbapenemase gene transmission between animals and humans and along the food chain at international level.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Diaconu EL, Carfora V, Alba P, et al. Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy. J Antimicrob Chemother. 2020. PMID: 32835381. doi:10.1093/jac/dkaa374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。